norovirus
FDA Clears Qiagen QiaStat-Dx Mini Gastrointestinal Panel
The assay detects five pathogens that cause acute gastrointestinal illness, complementing the firm's 16-target test.
FDA Clears Qiagen's Five-Target Syndromic GI Panel
The firm said it is the first to have both comprehensive and targeted qPCR panels to detect gastrointestinal pathogens.
After comparing manual methods with the firm's pcr.ai tool in more than 20,000 cases, they found that the use of AI improved test accuracy and reliability.
Abacus Diagnostica Norovirus Test Gets CE Mark, Firm Inks New Distribution Deal
The test detects and differentiates norovirus genogroups I and II directly from stool without RNA extraction.
Luminex Q2 Revenues Up 19 Percent; Firm to Delay Verigene 2 FDA Submission
The firm said that it is delaying clinical trials prior to its FDA submission of Verigene 2 for several reasons, including reducing cassette failure rates.